Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Setting the IMPACT (IMProve Access to Clinical Trial data) Observatory baseline.

Mahmić-Kaknjo M, Šimić J, Krleža-Jerić K.

Biochem Med (Zagreb). 2018 Feb 15;28(1):010201. doi: 10.11613/BM.2018.010201. Review.

2.

Essential medicines availability is still suboptimal in many countries: a scoping review.

Mahmić-Kaknjo M, Jeličić-Kadić A, Utrobičić A, Chan K, Bero L, Marušić A.

J Clin Epidemiol. 2018 Jun;98:41-52. doi: 10.1016/j.jclinepi.2018.02.006. Epub 2018 Feb 13. Review.

PMID:
29452222
3.

Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.

Hodžić H, Bajramović A, Obradović Z, Mahmić-Kaknjo M.

Med Glas (Zenica). 2017 Feb 1;14(1):73-78. doi: 10.17392/880-16.

4.

Anatomic variations of posterior paranasal sinuses and optic nerve.

Efendić A, Muharemović E, Skomorac R, Bečulić H, Šestić S, Halilović B, Mahmić-Kaknjo M.

Med Glas (Zenica). 2017 Feb 1;14(1):49-54. doi: 10.17392/875-16.

5.

IMPACT Observatory: tracking the evolution of clinical trial data sharing and research integrity.

Krleža-Jerić K, Gabelica M, Banzi R, Martinić MK, Pulido B, Mahmić-Kaknjo M, Reveiz L, Šimić J, Utrobičić A, Hrgović I.

Biochem Med (Zagreb). 2016 Oct 15;26(3):308-307. Review.

6.

Use of Health Technology Assessment Agencies' Reports As Evidence For Making Decisions On Drug Reimbursement In Decentralized Decision-Making Environment.

Mahmic-Kaknjo M, Marusic A.

Clin Ther. 2016 Oct 6;38(10S):e30. doi: 10.1016/j.clinthera.2016.07.161. No abstract available.

PMID:
27673659
7.

Decentralized Decision Making On Drug Reimbursement In A Middle-Income Country: Case Of Bosnia And Herzegovina.

Mahmic-Kaknjo M, Marusic A.

Clin Ther. 2016 Oct 6;38(10S):e17. doi: 10.1016/j.clinthera.2016.07.126. No abstract available.

PMID:
27673623
8.

Transition from paternalism to shared decision making - a review of the educational environment in Bosnia and Herzegovina and Croatia.

Vučemilović M, Mahmić-Kaknjo M, Pavličević I.

Acta Med Acad. 2016 May;45(1):61-9. doi: 10.5644/ama2006-124.157. Review.

9.

FIRST BH COCHRANE SYMPOSIUM HELD.

Mahmic-Kaknjo M, Novo A, Krleza-Jeric K.

Mater Sociomed. 2016 Feb;28(1):74-6. doi: 10.5455/msm.2016.28.74-76. Epub 2016 Jan 30.

10.

Awareness, knowledge, use, and attitudes toward evidence based medicine in a developing country: survey of physicians in a canton in Bosnia and Herzegovina.

Mahmić-Kaknjo M, Kadić D, Hodžić H, Spahić-Sarajlić S, Hadžić E, Ademović E.

Croat Med J. 2015 Dec;56(6):558-66.

11.

Cochrane and its prospects in Bosnia and Herzegovina: Relying on Cochrane Croatia.

Mahmić-Kaknjo M, Puljak L, Markotić F, Fidahić M, Muhamedagić L, Zakarija-Grković I.

Acta Med Acad. 2015;44(1):58-67. doi: 10.5644/ama2006-124.127.

12.
13.

Clinical importance of independent prognostic factors for renal parenchymal carcinoma and a possibility of predicting the treatment outcome.

Hodžić H, Bazardžanović M, Jagodić S, Hiroš M, Kulovac B, Oruč M, Mahmić-Kaknjo M.

Med Glas (Zenica). 2014 Aug;11(2):339-44.

PMID:
25082250
14.

Clinical importance of dependent prognostic factors for renal parenchymal carcinoma and a possibility of predicting the treatment outcome.

Hodžić H, Bazardžanović M, Jagodić S, Hiroš M, Kulovac B, Oruč M, Mahmić-Kaknjo M.

Med Glas (Zenica). 2014 Feb;11(1):145-51.

PMID:
24496356

Supplemental Content

Loading ...
Support Center